CN Stock MarketDetailed Quotes
301367 BMC Medical
- 69.94
- -0.94-1.33%
Market Closed Nov 15 15:00 CST
6.27BMarket Cap41.24P/E (TTM)
71.30High69.69Low8.84KlotVolume70.66Open70.88Pre Close62.36MTurnover1.56%Turnover Ratio21.07P/E (Static)89.60MShares95.7552wk High2.24P/B3.95BFloat Cap50.3652wk Low85.06Limit Up56.52MShs Float236.34Historical High56.70Limit Down2.27%Amplitude50.36Historical Low0.71Dividend TTM70.58Avg Price5.62KlotAsk1.02%Div YieldTTM100Lot Size3.00KlotBid
BMC Medical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -25.25%305.22M | 40.44%523.97M | 25.29%397.34M | 88.24%670.35M | 107.85%408.34M | 39.34%373.08M | --317.15M | 212.54%356.11M | --196.46M | 155.13%267.74M |
| Transactional financial assets | 13.44%2.33B | -5.40%2.01B | -3.67%2.18B | -16.09%1.81B | 414.43%2.06B | 555.39%2.12B | --2.27B | 632.20%2.16B | --400M | 19.12%324M |
| Notes receivable and accounts receivable | 21.92%178.21M | -8.81%125.47M | -9.86%122.89M | 24.04%127.68M | 63.71%146.18M | 219.98%137.59M | --136.32M | 224.66%102.94M | --89.29M | 18.70%43M |
| -Notes receivable | 502.28%32.5M | 131.74%14.42M | ---- | 85.42%19.11M | 2.01%5.4M | 3.69%6.22M | --2.27M | 41.57%10.3M | --5.29M | -23.12%6M |
| -Accounts receivable | 3.50%145.71M | -15.46%111.05M | -8.33%122.89M | 17.21%108.58M | 67.60%140.78M | 255.06%131.37M | --134.05M | 279.21%92.64M | --84M | 30.19%37M |
| Other receivables (including interest and dividends) | 44.03%5.4M | 17.78%4.47M | 24.27%4.48M | 92.88%3.9M | 69.69%3.75M | 174.61%3.8M | --3.61M | 95.50%2.02M | --2.21M | 29.70%1.38M |
| -Dividend receivable | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Accrued interest receivable | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Other receivable | ---- | 17.78%4.47M | ---- | ---- | ---- | --3.8M | --3.61M | 95.50%2.02M | ---- | ---- |
| Contractual assets | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Advance payment | 32.90%16.44M | 3.58%13.5M | 16.76%12.25M | 4.25%9.05M | 34.04%12.37M | 16.25%13.03M | --10.49M | 88.19%8.68M | --9.23M | 3.80%11.21M |
| Inventories | -25.55%109.34M | -29.59%116.97M | -42.76%103.2M | -41.95%118.01M | -9.24%146.88M | -1.38%166.12M | --180.3M | 73.44%203.31M | --161.83M | 124.23%168.45M |
| Receivable financing | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Assets held for sale | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Non-current assets due within one year | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other current assets | 125.09%12.19M | 423.27%28.98M | 105.56%36.68M | 211.08%49.32M | -88.20%5.42M | -72.89%5.54M | --17.85M | -38.88%15.85M | --45.9M | 104.45%20.43M |
| Total current assets | 6.49%2.96B | -0.02%2.82B | -2.45%2.86B | -2.04%2.79B | 207.28%2.78B | 237.55%2.82B | --2.93B | 383.31%2.85B | --904.91M | 63.91%836.21M |
| Non Current assets | ||||||||||
| Debt investment | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other debt investment | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other equity investment | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other non-current financial assets | 135.50%47.1M | 80.00%36M | --30M | --30M | --20M | --20M | --0 | ---- | ---- | ---- |
| Investment real estate | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Long-term equity investment | 1,121.76%157.32M | 551.56%83.97M | -2.06%12.5M | --12.74M | 100.69%12.88M | 131.66%12.89M | --12.76M | ---- | --6.42M | 52.02%5.56M |
| Long term receivable account | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Fixed assets | ---- | 12.86%33.1M | ---- | ---- | ---- | --29.32M | ---- | 100.58%27.37M | ---- | ---- |
| Productive biological assets | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Oil and gas assets | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Intangible assets | -9.47%6.04M | -14.50%6.02M | -23.66%5.78M | -22.35%6.3M | 254.91%6.67M | 230.42%7.04M | --7.57M | 223.74%8.11M | --1.88M | -23.92%2.13M |
| Development expenditure | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Goodwill | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Long deferred expense | -23.74%8.9M | -17.61%9.77M | 11.55%10.42M | 29.66%10.71M | 49.44%11.67M | 130.32%11.86M | --9.34M | 54.59%8.26M | --7.81M | -15.71%5.15M |
| Deferred tax assets | -63.90%4.56M | -73.31%2.91M | -54.55%3.18M | -42.20%3.56M | 715.03%12.63M | 435.92%10.91M | --7.01M | 345.04%6.17M | --1.55M | 19.70%2.04M |
| Usufruct assets | -23.38%18.94M | -25.54%21.48M | -22.86%22.15M | 21.59%24.64M | 150.90%24.72M | 175.87%28.84M | --28.72M | 500.96%20.27M | --9.85M | 96.92%10.46M |
| Other non current assets | 11.03%7.5M | 20.10%5.9M | -28.10%4.24M | -42.47%4.41M | -49.95%6.76M | 23.25%4.91M | --5.9M | 174.83%7.67M | --13.5M | 147.56%3.99M |
| Total non current assets | 123.38%282.5M | 58.33%199.14M | 24.35%122.07M | 64.13%127.77M | 121.36%126.47M | 177.40%125.78M | --98.16M | 127.39%77.84M | --57.13M | 43.26%45.34M |
| Total assets | 11.57%3.24B | 2.47%3.02B | -1.59%2.98B | -0.28%2.92B | 202.18%2.91B | 234.46%2.95B | 340.96%3.03B | 369.26%2.93B | --962.04M | 62.71%881.56M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | --30.02M | --30.01M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Transactional financial liabilities | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Notes payable and accounts payable | 214.61%105.22M | -22.51%69.91M | -66.64%45.7M | -61.52%39.73M | -73.02%33.44M | -38.48%90.23M | --136.97M | 50.01%103.26M | --123.98M | 128.00%146.65M |
| -Notes payable | --33.89M | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Accounts payable | 113.27%71.33M | -22.51%69.91M | -66.64%45.7M | -61.52%39.73M | -73.02%33.44M | -38.48%90.23M | --136.97M | 50.01%103.26M | --123.98M | 128.00%146.65M |
| Contract liabilities | 251.96%74.12M | 35.84%54.27M | 10.73%41.17M | -72.77%27.94M | 17.01%21.06M | 14.35%39.95M | --37.18M | 281.60%102.6M | --18M | 10.88%34.94M |
| Advance receipts | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Salaries payable | 41.91%31.9M | 39.23%24.37M | 13.57%18.07M | -23.45%25.82M | 20.26%22.48M | 18.70%17.5M | --15.91M | 43.87%33.73M | --18.69M | 41.62%14.74M |
| Taxs payable | 100.75%13.43M | -55.84%5.1M | -69.56%8.57M | -84.36%5.06M | -70.17%6.69M | -48.82%11.54M | --28.16M | 1,038.53%32.37M | --22.42M | 211.51%22.55M |
| Other payable (including interest and dividends) | 51.15%626.1K | 133.91%546.65K | -13.48%522.23K | 41.69%897.63K | -89.88%414.21K | -94.11%233.7K | --603.6K | -84.82%633.53K | --4.09M | 32.31%3.97M |
| -Interest payable | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Dividend payable | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Other payable | ---- | 133.91%546.65K | ---- | ---- | ---- | --233.7K | --603.6K | -84.82%633.53K | ---- | ---- |
| Hold and for sell liabilities | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Non current liabilities due within one year | 6.56%10.36M | 15.68%10.73M | 32.50%10.68M | 178.03%10.35M | 278.20%9.72M | 273.36%9.28M | --8.06M | 136.47%3.72M | --2.57M | -8.35%2.48M |
| Other current liabilities | 10,873.25%158.68M | 42.66%6.39M | 3.61%4.07M | -81.27%2.45M | -7.54%1.45M | 90.35%4.48M | --3.93M | 1,716.25%13.06M | --1.56M | 53.13%2.35M |
| Total current liabilities | 345.50%424.34M | 16.23%201.33M | -44.21%128.77M | -61.21%112.25M | -50.21%95.25M | -23.93%173.21M | --230.8M | 125.24%289.38M | --191.31M | 88.59%227.69M |
| Current liabilities | ||||||||||
| Long term loan | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Bonds payable | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Preferred stock | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Perpetual Debt | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Long term salaries pay | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Estimate liabilities | 13.11%1.55M | -5.87%1.5M | 4.66%1.66M | 55.16%2.23M | 11.80%1.37M | 67.73%1.6M | --1.58M | 66.91%1.44M | --1.22M | 18.59%952.55K |
| Deferred tax liabilities | -87.80%582.29K | -88.32%634.9K | -67.66%687.38K | -50.80%740.18K | --4.77M | --5.44M | --2.13M | --1.5M | ---- | ---- |
| Long term deferred income | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Lease liabilities | -39.34%10.37M | -40.27%12.7M | -37.71%13.65M | -5.42%16.4M | 99.18%17.1M | 132.08%21.26M | --21.92M | 583.61%17.34M | --8.59M | 211.35%9.16M |
| Other non current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Total non current liabilities | -46.20%12.5M | -47.56%14.84M | -37.58%16M | -4.49%19.37M | 136.94%23.24M | 179.77%28.3M | --25.63M | 415.12%20.28M | --9.81M | 135.09%10.11M |
| Total liabilities | 268.68%436.84M | 7.28%216.16M | -43.54%144.77M | -57.50%131.62M | -41.09%118.49M | -15.26%201.5M | 77.11%256.43M | 133.86%309.66M | --201.12M | 90.19%237.8M |
| Shareholders equity | ||||||||||
| Paid-in capital | 40.00%89.6M | 40.00%89.6M | 0.00%64M | 0.00%64M | 33.33%64M | 33.33%64M | --64M | 33.33%64M | --48M | 0.00%48M |
| Other equity instruments | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Equity of prefer stock | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Equity of Perpetual debt | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Capital reserve funds | -3.00%1.75B | -2.22%1.75B | 0.00%1.77B | 0.00%1.77B | 3,462.40%1.8B | 3,434.22%1.79B | --1.77B | 3,406.26%1.77B | --50.56M | 0.00%50.56M |
| Surplus reserve funds | 0.00%32M | 0.00%32M | 0.00%32M | 0.00%32M | 21.06%32M | 21.06%32M | --32M | 21.06%32M | --26.43M | 0.00%26.43M |
| Retained profit | 10.21%971.59M | 9.84%938.84M | 7.13%960.38M | 22.85%910.47M | 38.63%881.6M | 64.76%854.71M | --896.45M | 102.34%741.13M | --635.93M | 77.79%518.76M |
| Less:Treasury stock | --42.26M | --11.52M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other composite income | 141.30%11.12K | ---13.55K | ---17.31K | ---4.26K | ---26.92K | ---- | --0 | --0 | ---- | ---- |
| Ordinary risk reserve funds | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Specific reserves | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Shareholders equity without minority interests | 0.70%2.8B | 2.14%2.8B | 2.31%2.83B | 6.49%2.78B | 265.19%2.78B | 325.27%2.74B | --2.77B | 431.26%2.61B | --760.93M | 54.46%643.75M |
| Minority interests | -13.84%8.47M | -2.55%8.99M | -3.34%8.28M | 6.88%7.64M | --9.83M | --9.22M | --8.57M | --7.15M | ---- | ---- |
| Total shareholder equity | 0.65%2.81B | 2.12%2.81B | 2.29%2.84B | 6.49%2.79B | 266.48%2.79B | 326.70%2.75B | 411.39%2.77B | 432.71%2.62B | --760.93M | 54.46%643.75M |
| Total liabilityies and equity | 11.57%3.24B | 2.47%3.02B | -1.59%2.98B | -0.28%2.92B | 202.18%2.91B | 234.46%2.95B | 340.96%3.03B | 369.26%2.93B | --962.04M | 62.71%881.56M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data